 |
|
Women under-represented in cancer research, U-M study finds
June 08, 2009ANN ARBOR, Mich. - Women are under-represented in clinical cancer research published in high-impact journals, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
Taking into account the incidence of particular types of cancer among women, studies included a smaller proportion of women than should be expected. The analysis looked specifically at studies of cancer types that were not gender specific, including colon cancer, oral cancers, lung cancer, brain tumors and lymphomas.
The authors looked at 661 prospective clinical studies with more than 1 million total participants. Results of this study appear online in the journal Cancer and will be published in the July 15 print issue.
"In the vast majority of individual studies we analyzed, fewer women were enrolled than we would expect given the proportion of women diagnosed with the type of cancer being studied. We're seeing it across the board in all cancer types," says study author Reshma Jagsi, M.D., D.Phil., assistant professor of radiation oncology at the U-M Medical School.
"It's so important that women are appropriately represented in research. We know there are biological differences between the sexes, as well as social and cultural differences. Studies need to be able to assess whether there are differences in responses to treatment, for example, between women and men," she adds.
The National Institutes of Health's Revitalization Act of 1993 explicitly calls out the importance of including women in clinical research, noting that clinical trials should enroll adequate numbers of women to allow for subgroup analysis.
The U-M researchers found that studies reporting government funding did include higher numbers of women participants, but the impact was modest - 41 percent, compared to 37 percent for studies not receiving government funding.
Traditionally, researchers were told not to include people of vulnerable populations in their studies. This group included women of childbearing age. "By protecting them from research, we're excluding them," Jagsi notes.
Previous studies have found some barriers to clinical trial participation are lack of information, fear and a perception of interfering with personal responsibilities, such as child care.
"Sometimes participating in research studies can be time intensive. Women today are often stretched very thin trying to deal with the balance between domestic responsibilities, their cancer diagnosis, and often a career as well. They may be particularly likely to find clinical trials too burdensome. In that case, researchers should consider providing compensation to help with transportation or child care expenses," Jagsi says.
This under-representation of women is not necessarily the result of conscious decisions, points out senior author Peter Ubel, M.D., director of the Center for Behavioral and Decision Sciences in Medicine at U-M.
"Clinical researchers are not purposely trying to exclude women from their studies. All the more reason they need to consciously and earnestly revise their recruitment methods to give more women a chance to volunteer," Ubel says.
University of Michigan Health System
"In the vast majority of individual studies we analyzed, fewer women were enrolled than we would expect given the proportion of women diagnosed with the type of cancer being studied. We're seeing it across the board in all cancer types," says study author Reshma Jagsi, M.D., D.Phil., assistant professor of radiation oncology at the U-M Medical School.
"It's so important that women are appropriately represented in research. We know there are biological differences between the sexes, as well as social and cultural differences. Studies need to be able to assess whether there are differences in responses to treatment, for example, between women and men," she adds.
The National Institutes of Health's Revitalization Act of 1993 explicitly calls out the importance of including women in clinical research, noting that clinical trials should enroll adequate numbers of women to allow for subgroup analysis.
The U-M researchers found that studies reporting government funding did include higher numbers of women participants, but the impact was modest - 41 percent, compared to 37 percent for studies not receiving government funding.
Traditionally, researchers were told not to include people of vulnerable populations in their studies. This group included women of childbearing age. "By protecting them from research, we're excluding them," Jagsi notes.
Previous studies have found some barriers to clinical trial participation are lack of information, fear and a perception of interfering with personal responsibilities, such as child care.
"Sometimes participating in research studies can be time intensive. Women today are often stretched very thin trying to deal with the balance between domestic responsibilities, their cancer diagnosis, and often a career as well. They may be particularly likely to find clinical trials too burdensome. In that case, researchers should consider providing compensation to help with transportation or child care expenses," Jagsi says.
This under-representation of women is not necessarily the result of conscious decisions, points out senior author Peter Ubel, M.D., director of the Center for Behavioral and Decision Sciences in Medicine at U-M.
"Clinical researchers are not purposely trying to exclude women from their studies. All the more reason they need to consciously and earnestly revise their recruitment methods to give more women a chance to volunteer," Ubel says.
University of Michigan Health System
Cancer Research Current Events and Cancer Research News RSSCommon pain relief medication may encourage cancer growth
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence
A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning.
'Cross-talk' mechanism contributes to colorectal cancer
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors.
No-entry zones for AIDS virus
The AIDS virus inserts its genetic material into the genome of the infected cell. Scientists of the German Cancer Research Center have now shown for the first time that the virus almost entirely spares particular sites in the human genetic material in this process. This finding may be useful for developing new, specific AIDS drugs.
Quarter of a million children in England at risk of skin cancer from sunbeds
An estimated quarter of a million 11-17 year olds in England are being put at increased risk of developing malignant melanoma by using sunbeds, warn researchers in a letter to this week's BMJ.
Iowa State University researcher discovers key to vital DNA, protein interaction
A researcher at Iowa State University has discovered how a group of proteins from plant pathogenic bacteria interact with DNA in the plant cell, opening up the possibility for what the scientist calls a "cascade of advances."
New mechanism explains how the body prevents formation of blood vessels
Researchers at Uppsala University, in collaboration with colleagues in Sweden and abroad, have identified an entirely new mechanism by which a specific protein in the body inhibits formation of new blood vessels.
Newly Discovered Fat Molecule: An Undersea Killer with an Upside
A chemical culprit responsible for the rapid, mysterious death of phytoplankton in the North Atlantic Ocean has been found by collaborating scientists at Rutgers University and the Woods Hole Oceanographic Institution (WHOI). This same chemical may hold unexpected promise in cancer research.
Scientists uncover new key to the puzzle of hormone therapy and breast cancer
The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer.
First use of antibody and stem cell transplantation to successfully treat advanced leukemia
For the first time, researchers at Fred Hutchinson Cancer Research Center have reported the use of a radiolabeled antibody to deliver targeted doses of radiation, followed by a stem cell transplant, to successfully treat a group of leukemia and pre-leukemia patients for whom there previously had been no other curative treatment options.
More Cancer Research Current Events and Cancer Research News Articles
 |
Pink Snuggie Blanket - Purchase BenefitsThe Breast Cancer Research Foundation by Bewild - Pink Snuggie Blanket |
 |
The Secret History of the War on Cancer by Devra Davis (Author) Why has the “War on Cancer” languished, focusing mainly on finding and treating the disease and downplaying the need to control and combat cancer’s basic causes—tobacco, the workplace, radiation, and the general environment? This war has targeted the wrong enemies with the wrong weapons, failing to address well-known cancer causes. As epidemiologist Devra Davis shows in this superbly researched exposé, this is no accident. The War on Cancer has followed the commercial interests of industries that generated a host of cancer-causing materials and products. This is the gripping story of a major public health effort diverted and distorted for private gain that is being reclaimed through efforts to green health care and the environment. |
 |
Master Lock 1530DPNK Breast Cancer Research Foundation Dial Combination Lock, Pink by Master Lock |
|
Annals of Cancer Research and Therapy by Pjd Publs Ltd | |
 |
Little Pink Drill $49-10% Donated to Breast Cancer Research! by Little Pink Tools 18 volt cordless rechargable drill specifically designed for women. Attractive and lightweight at only 3.25 lbs. Perfect for all your home maintenance! 1 year guarantee on drill, batteries and charger. |
 |
Nova - Cancer Warrior Starring: Liev Schreiber Directed By: Nancy Linde Studio: Wgbh Wholesale Release Date: 10/02/2001 Run time: 60 minutes |
 |
Charmed Life Products The Pink Collection for Breast Cancer Research Grill Charms by Charmed Life Products LLC Grill Charms: The must have grilling accessory that is revolutionizing the American cook-out. Similar in concept to the wine charm these dime-sized solid stainless steel charms are placed in your food before grilling. The stems are serrated to hold securely while grilling, moving and flipping. The Pink Collection has six individual and unique designs such as a shoe, a wine glass, and a ribbon. If someone likes extra garlic, someone else likes extra pepper and someone else has health concerns with MSG, with Grill Charms each person chooses their own Grill Charm and they can season their food any way they wish, without fear of a mix up on the grill. Personalize your food prior to cooking to distinguish spices and flavors, to avoid health or allergy issues or any other OPTION you can dream... |
 |
Swiss Army SwissCard Pink - Breast Cancer Awareness (Portion Donated to Research) by Victorinox SwissCards are so innovative that they won an award for highest design quality, expressing innovation in form and function. They make an excellent gift for any woman or girl, to keep in a purse or for school, work or home. A portion of the proceeds from the sale of this SwissCard goes toward breast cancer research. Features include: 1. Small blade/letter opener. 2. Useful scissors, 3-4. Mini-ruler (cm and inches), 5. Stainless steel pin, 6. Ballpoint pen, and 7. Tweezers. Made in Switzerland and guaranteed for life. |
 |
Pink Snuggie Blanket - Purchase BenefitsThe Breast Cancer Research Foundation by Bewild The SnuggieTM keeps you totally warm and gives you the freedom to use your hands. Work the remote, use your laptop or do some reading in total warmth and comfort! SnuggieTM is made with super soft, thick, luxurious fleece with roomy, oversized sleeves that let you do what you want while still being totally wrapped in warmth. Everyone has heard of the Snuggie blanket with sleeves by now. This winters weather was nothing up against my Snuggie. No blanket compares to the Snuggie because it is the only one with sleeves. There is nothing like curling up to a movie, with your Snuggie blanket with sleeves. The Snuggie blanket with sleeves is the only one out there. This innovative new product is simply amazing. Just think no more fumbling around with those average blankets. All you have to do is... |
 |
Pink Leather Lipstick Holder Supports Breast Cancer Research - Pink by Day-Timers Pink Leather Lipstick Holder Supports Breast Cancer Research Presenting our luxurious pink leather lipstick holder made of soft, pebble-grain leather exterior with rich, chocolate brown painted edges and chocolate suede interior. Keeps lipstick protected. Thanks to research and awareness programs, breast cancer survivors are living longer than ever before. Day-Timer will donate approximately 3-10% of the price of Pink Ribbon products to the Breast Cancer Research Foundation. To date, Day-Timer has contributed over $515,000. |
| © 2009 BrightSurf.com |